Intraaortic balloon assistance in intractable cardiogenic shock

Related Experiment Video

Updated: May 6, 2026

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

27.2K

S Moulopoulos, S Stamatelopoulos, P Petrou

    European Heart Journal
    |May 1, 1986
    PubMed

    Insights

    Intraaortic counterpulsation (IABP) may improve survival in patients with severe cardiogenic shock post-myocardial infarction when conventional treatments fail. This study suggests IABP offers a life-saving option for intractable cases.

    Area of Science:

    • Cardiology
    • Critical Care Medicine
    • Medical Devices

    Background:

    • Severe cardiogenic shock post-myocardial infarction (MI) has a high mortality rate.
    • The effectiveness of intraaortic counterpulsation (IABP) in such cases remains debated due to limited controlled data.

    Purpose of the Study:

    • To evaluate the efficacy of intraaortic counterpulsation (IABP) in patients with severe, intractable cardiogenic shock following acute myocardial infarction.

    Main Methods:

    • Observational study of 52 patients with severe cardiogenic shock post-MI.
    • Comparison of outcomes between patients treated with IABP and those receiving conventional therapy or non-functioning IABP devices.

    Main Results:

    • Only 3 of 52 patients improved with conventional treatment alone.
    • Of 34 patients treated with IABP for intractable shock, 10 survived longer than one month.
    • None of the 15 control patients with non-functioning IABP survived.

    Conclusions:

    • Intraaortic counterpulsation (IABP) can be a life-saving intervention for patients with severe, protracted cardiogenic shock unresponsive to other treatments.
    • IABP demonstrates potential benefit in a high-risk patient population where conventional therapies have failed.

    More Related Videos

    Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

    Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

    Published on: August 16, 2021

    3.3K
    Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock06:30

    Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock

    Published on: May 19, 2022

    10.6K

    Related Concept Videos

    Aortic Regurgitation III: Medical Management01:25

    Aortic Regurgitation III: Medical Management

    Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
    598
    Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

    Cardiopulmonary Resuscitation IV: Pharmacological Management

    Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
    1.7K
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    635
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    761